Literature DB >> 27401334

Preparation and Optimization of Immediate Release/Sustained Release Bilayered Tablets of Loxoprofen Using Box-Behnken Design.

Jin Wook Tak1, Biki Gupta1, Raj Kumar Thapa1, Kyu Bong Woo1, Sung Yub Kim1, Toe Gyeong Go1, Yongjoo Choi1, Ju Yeon Choi1, Jee-Heon Jeong1, Han-Gon Choi2, Chul Soon Yong3, Jong Oh Kim4.   

Abstract

The aim of our current study was to characterize and optimize loxoprofen immediate release (IR)/sustained release (SR) tablet utilizing a three-factor, three-level Box-Behnken design (BBD) combined with a desirability function. The independent factors included ratio of drug in the IR layer to total drug (X 1), ratio of HPMC to drug in the SR layer (X 2), and ratio of Eudragit RL PO to drug in the SR layer (X 3). The dependent variables assessed were % drug released in distilled water at 30 min (Y 1), % drug released in pH 1.2 at 2 h (Y 2), and % drug released in pH 6.8 at 12 h (Y 3). The responses were fitted to suitable models and statistical validation was performed using analysis of variance. In addition, response surface graphs and contour plots were constructed to determine the effects of different factor level combinations on the responses. The optimized loxoprofen IR/SR tablets were successfully prepared with the determined amounts of ingredients that showed close agreement in the predicted and experimental values of tablet characterization and drug dissolution profile. Therefore, BBD can be utilized for successful optimization of loxoprofen IR/SR tablet, which can be regarded as a suitable substitute for the current marketed formulations.

Entities:  

Keywords:  Box–Behnken design; loxoprofen; optimization; sustained release

Mesh:

Substances:

Year:  2016        PMID: 27401334     DOI: 10.1208/s12249-016-0580-5

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  5 in total

1.  Medium optimization to analyze the protein composition of Bacillus pumilus HR10 antagonizing Sphaeropsis sapinea.

Authors:  Yun Dai; Ya-Hui Wang; Min Li; Mei-Ling Zhu; Tong-Yue Wen; Xiao-Qin Wu
Journal:  AMB Express       Date:  2022-05-23       Impact factor: 4.126

2.  Development and In Vitro-In Vivo Evaluation of a Novel Sustained-Release Loxoprofen Pellet with Double Coating Layer.

Authors:  Dongwei Wan; Min Zhao; Jingjing Zhang; Libiao Luan
Journal:  Pharmaceutics       Date:  2019-06-05       Impact factor: 6.321

3.  Development of omega-3 loxoprofen-loaded nanoemulsion to limit the side effect associated with NSAIDs in treatment of tooth pain.

Authors:  Khaled M Hosny; Amal M Sindi; Hala M Alkhalidi; Mallesh Kurakula; Amira H Hassan; Rana B Bakhaidar; Walaa A Abualsunun; Alshaimaa M Almehmady; Ahmed Khames; Waleed Y Rizg; Rasha A Khallaf; Nabil K Alruwaili; Nabil A Alhakamy
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

4.  Study on microwave assisted extraction of chrysophanol and its intervention in biofilm formation of Streptococcus suis.

Authors:  Jing-Wen Bai; Xing-Ru Chen; Yang Tang; Wen-Qiang Cui; Da-Long Li; Bello-Onaghise God'spower; Yu Yang
Journal:  RSC Adv       Date:  2019-09-17       Impact factor: 4.036

5.  Process optimization of Syringa oblata Lindl. by response surface methodology and its effect on Staphylococcus xylosus biofilm.

Authors:  Xing-Ru Chen; Yan-Yan Liu; Yong-Hui Zhou; Xiao-Xu Xing; Qian-Wei Qu; Xue-Ying Chen; Wen-Ya Ding; Guang-Long Cheng; Ai-Juan Wei; Xi-Wen Feng; Bello-Onaghise God'spower; Nsabimana Eliphaz; Yan-Hua Li
Journal:  RSC Adv       Date:  2019-11-05       Impact factor: 4.036

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.